Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity

Table 1

Baseline patient characteristics.

Disease characteristic	Number of Patients (%)
Stage
T1	0 (0)
T2	19 (32)
T3	41 (68)
Gleason score
2-6	18 (30)
7	27 (45)
8–10	15 (25)
Presenting PSA (μg/L)
<10	12 (20)
10–20	14 (23)
>20	34 (57)